-19 outbreak in many counties has not been resolved. Such current situation may have a negative impact on Thai listed companies that have core business in COVID-19 affected countries, or it might
According to the findings of SEC inspection on the operation of SKFM whose main business is private fund management, in 2018 Mr. King, CEO and fund manager of the company at the time, acted in the following manners: (1) funneling damage incurred from investment among the clients of private funds by making cross-trade transactions of shares under trading suspension (SP) sign on a continual basis from 2015 to 2017; (2) managing private funds without taking the cli...
Facebook อ้างชื่อ Gold Care Thailand - ยังไม่ได้รับใบอนุญาตธุรกิจหลักทรัพย์/สัญญาซื้อขายล่วงหน้า (วันที่เปิดเผยข้อมูล : 19/03/2569)
Facebook อ้างชื่อ HSH Gold Care Center - ยังไม่ได้รับใบอนุญาตธุรกิจหลักทรัพย์/สัญญาซื้อขายล่วงหน้า (วันที่เปิดเผยข้อมูล : 27/10/2568)
At today’s press conference to announce the SEC Strategic Plan for 2025 - 2027, Deputy Prime Minister and Minister of Finance, Mr. Pichai Chunhavajira, delivered a keynote speech on “Developing Thailand’s Capital Market as a Driver of Economic Growth.” Professor Wisit Wisitsora-at, Chairman of the SEC Board, welcomed attendees and outlined the objectives of the event, while Professor Pornanong Budsaratragoon, Ph.D., SEC Secretary-General, gave an overview of the SEC strategic direction fo...
Line อ้างชื่อ Core Weave และ Line อ้างชื่อ Expert Aek - ยังไม่ได้รับใบอนุญาตธุรกิจหลักทรัพย์/สัญญาซื้อขายล่วงหน้า (วันที่เปิดเผยข้อมูล : 13/03/2569)
Period As Of Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 EKACHAI MEDICAL
Reset EKACHAI MEDICAL PUBLIC COMPANY LIMITED : EKH Form 56-2 : Annual Reports ( 8 record(s) found) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2023 26/03/2024 EKACHAI
downstream business in Integrated Oxides and Derivatives based out of advantaged Gulf Coast USA. Indorama Ventures 2nd Quarter 2019 MD&A 2 2Q 2019 Summary Financials Table 1: Core Financials of Consolidated
: +662 661 6664 Indorama Ventures 2nd Quarter 2020 MD&A 1 Executive Summary 2Q 2020 Financial Results • IVL achieved a core EBITDA of US$305M and an operating cash flow of US$300M. Core net profit grew to